Serum NT-proBNP Concentrations in Pediatric Patients with a History of Idiopathic Cardiac Arrhythmias: A Pilot Study.

Serum NT-proBNP concentrations were significantly higher in pediatric patients with a history of cardiac arrhythmias than in hospital-based controls.

• The study included 26 children and adolescents with idiopathic arrhythmias and 20 hospital-based controls without arrhythmias.
• NT-proBNP was measured by ELISA.
• Group differences were tested with the Mann-Whitney U test.
• The difference remained statistically significant specifically for the ventricular arrhythmias (VAs) subgroup.

The ventricular arrhythmias (VA) subgroup showed a statistically significant elevation in NT-proBNP compared to controls, while results for the supraventricular tachycardia (SVT) subgroup were not independently highlighted as significant.

• The VA subgroup consisted of n = 17 patients.
• The SVT subgroup consisted of n = 9 patients.
• The overall arrhythmia cohort was divided into these two diagnostic subgroups for subgroup analysis.
• Statistical significance was retained for the VAs subgroup specifically when compared to controls.

Treated pediatric arrhythmia patients had significantly lower NT-proBNP levels than untreated individuals.

• Treatment status was an independent variable examined in relation to NT-proBNP concentrations.
• The difference in NT-proBNP between treated and untreated patients was statistically significant.
• Specific treatment types or drug classes were not detailed in the abstract.
• This finding suggests NT-proBNP may reflect response to arrhythmia management.

NT-proBNP showed no significant associations with age, sex, echocardiographic parameters, or other laboratory parameters.

• Correlations were assessed using Spearman's coefficient.
• Echocardiography results were among the variables tested for correlation with NT-proBNP.
• The absence of correlation with echocardiographic parameters suggests NT-proBNP elevation is independent of structural cardiac abnormalities detectable by echo.
• No significant associations were found with any demographic or standard laboratory variables tested.

In the VAs subgroup, NT-proBNP was moderately negatively correlated with baseline QRS duration.

• The correlation was assessed using Spearman's coefficient.
• The direction of the correlation was negative, meaning higher NT-proBNP was associated with shorter QRS duration.
• The correlation strength was described as 'moderate.'
• This association was specific to the VAs subgroup (n = 17) and not reported for the SVT subgroup.

This was a pilot exploratory study with a limited patient population, and the authors caution that findings require further validation.

• Total arrhythmia patient sample size was 26 (VAs n = 17, SVT n = 9) with 20 controls.
• The study is explicitly described as 'a pilot exploratory analysis' due to the limited sample size.
• The authors recommend NT-proBNP be considered 'a supportive biomarker reflecting functional myocardial strain rather than a stand-alone diagnostic tool.'
• The heterogeneous clinical presentation of pediatric arrhythmias is noted as a diagnostic challenge context for these findings.